276 related articles for article (PubMed ID: 31377983)
21. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
Zhang W; Zhang L; Dong H; Peng H
Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
[TBL] [Abstract][Full Text] [Related]
22. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Xing W; Zeng C
Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
[TBL] [Abstract][Full Text] [Related]
23. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract][Full Text] [Related]
24. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
25. p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.
Yang F; Hu A; Guo Y; Wang J; Li D; Wang X; Jin S; Yuan B; Cai S; Zhou Y; Li Q; Chen G; Gao H; Zheng L; Tong Q
Mol Cancer; 2021 Sep; 20(1):123. PubMed ID: 34579723
[TBL] [Abstract][Full Text] [Related]
26. PLEKHG5 is a novel prognostic biomarker in glioma patients.
Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
[TBL] [Abstract][Full Text] [Related]
27. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.
Yang J; Liao D; Wang Z; Liu F; Wu G
J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387
[TBL] [Abstract][Full Text] [Related]
28. Distinct clinical and biological implications of
Aly M; Ramdzan ZM; Nagata Y; Balasubramanian SK; Hosono N; Makishima H; Visconte V; Kuzmanovic T; Adema V; Nazha A; Przychodzen BP; Kerr CM; Sekeres MA; Abazeed ME; Nepveu A; Maciejewski JP
Blood Adv; 2019 Jul; 3(14):2164-2178. PubMed ID: 31320321
[TBL] [Abstract][Full Text] [Related]
29. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
30. Over-Expressed FEZF1 Predicts a Poor Prognosis in Glioma and Promotes Glioma Cell Malignant Biological Properties by Regulating Akt-ERK Pathway.
Yu M; Yu S; Xue Y; Yu H; Chen D; Wei X; Liu Y
J Mol Neurosci; 2018 Aug; 65(4):411-419. PubMed ID: 30030762
[TBL] [Abstract][Full Text] [Related]
31. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114
[TBL] [Abstract][Full Text] [Related]
32. WTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients.
Xi Z; Xue Y; Zheng J; Liu X; Ma J; Liu Y
J Mol Neurosci; 2016 Oct; 60(2):131-6. PubMed ID: 27370540
[TBL] [Abstract][Full Text] [Related]
33. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
34. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
35. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
36. TGIF1 overexpression promotes glioma progression and worsens patient prognosis.
Wang B; Ma Q; Wang X; Guo K; Liu Z; Li G
Cancer Med; 2022 Dec; 11(24):5113-5128. PubMed ID: 35569122
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
38. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
Ding D; Song T; Jun W; Tan Z; Fang J
Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
[TBL] [Abstract][Full Text] [Related]
40. High Expression of Pirh2 is Associated with Poor Prognosis in Glioma.
Bao Y; Wu X; Yuan D; Shi W; Shi J
Cell Mol Neurobiol; 2017 Nov; 37(8):1501-1509. PubMed ID: 28258514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]